In vitro diagnostic medical device startup Allmade Co., Ltd. (CEO Taek-Kyu Oh) announced that it has attracted seed investment from Big Bang Hi-Tech Bio Investment Association (executive partner: Big Bang Ventures).
Through this investment, Allmade plans to fully pursue the development of next-generation in vitro diagnostic platform technology utilizing quantum dots. Quantum dots are ultra-fine semiconductor particles measuring from several nanometers to tens of nanometers (nm), and have the characteristic of emitting various colors depending on the particle size. Allmade is developing a diagnostic technology that combines quantum dots with biomaterials, and is also building a high-sensitivity sensing system that can precisely analyze signals.
Allmade, established in 2023, was selected for the Ministry of SMEs and Startups' 'Startup Growth Technology Development (RnD) Stepping Stone Project' in 2024 and is focusing on developing related technologies, aiming to launch a product in 2025.
Big Bang Ventures CEO Koo Tae-hoon explained the investment background, saying, “We decided to invest because Allmade’s quantum dot-based high-sensitivity diagnostic technology holds great potential in the global animal in vitro diagnostics market, especially in the livestock sector.”
“With this investment, we will target the niche market between rapid diagnosis and precision diagnosis and accelerate our successful market entry,” said Oh Taek-kyu, CEO of Allmade.
You must be logged in to post a comment.